About this trial
The MITRAGEN5 Registry is an international, multicenter, observational registry that collects data on patients with mitral regurgitation who are treated with the fifth-generation MitraClip (G5) device. The MitraClip is a small device used to repair the mitral valve of the heart without open-heart surgery, a procedure called mitral valve transcatheter edge-to-edge repair (M-TEER). This registry aims to evaluate how safe and effective the MitraClip G5 is in everyday clinical practice across multiple hospitals worldwide. All procedures, tests, and follow-up visits are part of routine clinical care. No additional study-specific procedures are performed. Data are collected in anonymized form from participating centers.
Eligibility criteria
Qualifiers
Age 18 years or older at the time of M-TEER
Treatment using the MitraClip G5 system
Disqualifiers
None
Trial design
Treatments tested in this trial
- MitraClip G5
Treatment groups
Locations
Sponsors and collaborators
University Hospital of Cologne
Lead sponsor
Montefiore Medical Center
Collaborator
Cardiovascular Research Foundation, New York
Collaborator